Recent TXG News
- Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer • PR Newswire (US) • 09/10/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 09:34:30 PM
- 10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research • PR Newswire (US) • 09/03/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 09:05:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 09:04:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 09:03:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/23/2024 12:45:27 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/23/2024 12:42:43 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/23/2024 12:39:54 AM
- 10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference • PR Newswire (US) • 08/22/2024 08:05:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:35:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:12:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:08:00 PM
- 10x Genomics Announces Senior Leadership Changes • PR Newswire (US) • 08/08/2024 08:05:00 PM
- 10x Genomics Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/08/2024 08:04:00 PM
- 10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform the Treatment of Complex Diseases • PR Newswire (US) • 08/05/2024 08:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/19/2024 08:42:05 PM
- 10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 • PR Newswire (US) • 07/12/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 08:08:09 PM
- Costco Hikes Membership Fees; ON Semiconductor Stock Drops 3%; WD-40 Soars 13% on Strong Q3 Earnings • IH Market News • 07/11/2024 10:17:26 AM
- New Insights Into Cleft Palate Unlocked With 10x Genomics' Single Cell and Spatial Technologies • PR Newswire (US) • 06/27/2024 01:00:00 PM
- 10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel • PR Newswire (US) • 06/20/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:08:01 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/06/2024 08:13:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 08:06:12 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM